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Summary
Edible fruits are inexpensive biofactories for human health-promoting molecules that can be
ingested as crude extracts or partially purified formulations. We show here the production of
a model human antibody for passive protection against the enteric pathogen rotavirus in
transgenically labelled tomato fruits. Transgenic tomato plants expressing a recombinant
human immunoglobulin A (hIgA_2A1) selected against the VP8* peptide of rotavirus SA11
strain were obtained. The amount of hIgA_2A1 protein reached 3.6 ± 0.8% of the total solu-
ble protein in the fruit of the transformed plants. Minimally processed fruit-derived products
suitable for oral intake showed anti-VP8* binding activity and strongly inhibited virus infection
in an in vitro virus neutralization assay. In order to make tomatoes expressing hIgA_2A1 easily
distinguishable from wild-type tomatoes, lines expressing hIgA_2A1 transgenes were sexually
crossed with a transgenic tomato line expressing the genes encoding Antirrhinum majus
Rosea1 and Delila transcription factors, which confer purple colour to the fruit. Consequently,
transgenically labelled purple tomato fruits expressing hIgA_2A1 have been developed. The
resulting purple-coloured extracts from these fruits contain high levels of recombinant anti-
rotavirus neutralizing human IgA in combination with increased amounts of health-promoting
anthocyanins.
Introduction
Fleshy fruit have been traditionally exploited as natural biofacto-
ries for orally active, health-promoting metabolites (Cipollini and
Levey, 1997). Recently, they have also been envisioned as an
excellent vehicle for nutritional enhancement, and considerable
efforts have been made to enrich their content of indigenous
and ⁄ or exotic human health-promoting compounds such as car-
otenoids, folate, flavonols or anthocyanins through molecular
breeding and metabolic engineering (Bovy et al., 2002, 2007;
Davuluri et al., 2005; Butelli et al., 2008; Giuliano et al., 2008;
Apel and Bock, 2009). Unlike other plant-derived products,
edible fruit and their derivatives are considered safe and palat-
able for human consumption in unheated, minimally processed
forms, and their content of antinutrients and toxic compounds
sharply decreases upon ripening. This feature makes edible
fruits ideal biofactories for exotic heat-labile compounds with
mucosal activity such as health-promoting metabolites and
mucosal active proteins like oral vaccines, immune modulators,
biocides and ⁄ or antibodies for artificial passive immunotherapy.
Transgenic crops have been proposed as advantageous
platforms for recombinant antibody production owing to their
productivity, scalability and the low risk of contamination with
mammalian pathogens (De Muynck et al., 2010). The technical
feasibility of an artificial passive immunization approach based
on a plant-made antibody was first demonstrated by the pio-
neering work of Ma et al. (1994, 1995, 1998) who expressed in
tobacco a hybrid murine ⁄ human secretory immunoglobulin G ⁄A
(Guy¢s 13 sIgG ⁄A) that is effective against tooth decay. The
Guy¢s 13 monoclonal antibody produced in tobacco provided
effective protection against Streptococcus mutans infections in
healthy volunteers. The technology to express Guy’s 13 sIgG-A
in plants was licensed by Planet Biotechnology Inc (Hayward,
CA). This was the first plant-made antibody that was evaluated
in phase I and II clinical trials (Weintraub et al., 2005) as
CaroRxTM. In the United States, CaroRx is an Investigational
New Drug, and in the European Union, it is a registered Medical
Device. More recently, the anti-HIV monoclonal IgG 2G12 was
successfully produced in corn with the aim of conferring passive
protection of vaginal mucosa against HIV infection (Rademacher
et al., 2008). Plant-derived IgG 2G12 was shown to be effective
in viral inhibition assays and has become a promising cost-effec-
tive source for vaginal gel formulations (Ramessar et al., 2008).
Antibody purification is still a major component of the total
cost of goods in plant-made recombinant antibody production
(Hood et al., 2002). Although biosafety of any therapeutic ⁄ pro-
phylactic approach involving complex botanical mixes should be
exhaustively investigated, it is expected that minimally processed
extracts from antibody-producing edible fruits can be used as
safe formulations for mucosal delivery, therefore reducing
downstream processing costs. Tomato fruits have been studied
as successful production platforms for recombinant oral vac-
cines (Walmsley et al., 2003; Zhang et al., 2006). However,
issues such as the capacity of fleshy fruits to accumulate func-
tional antibodies, the evolution of antibody activity throughout
the process of fruit ripening and the formulations that retain
neutralizing activity have not been addressed before. To address
these issues, we assessed the recombinant production in
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tomato fruit of a phage display–derived human IgA antibody
that is effective against the model rotavirus strain SA11, and
tested the ability of minimally processed fruit-derived products
to neutralize rotavirus infection in vitro.
Besides antibody activity and formulation, an important con-
cern in using edible fruits to produce recombinant pharmaceuti-
cals stems from the possibility that the fruit expressing
pharmaceuticals are mixed with fruit used for food consump-
tion. To address this issue, it has been recommended that trans-
genic fruit should be labelled with distinctive features that help
to preserve their identity, facilitate traceability and avoid the
contamination of the food supply. As a proof of this concept,
we engineered purple, IgA-producing tomatoes, where Antirrhi-
num majus Rosea1 and Delila transcription factors, known to
ectopically activate anthocyanin biosynthesis in tomato fruits
(Butelli et al., 2008), were incorporated into the transgenic IgA
background by sexual crossing to obtain tomato-made antibod-
ies in transgenically labelled fruit and fruit-derived products.
Results
Design and selection of human IgA genes for
expression in tomato fruits
Antibody repertoires displayed in phage format provide a flexi-
ble and adaptable source of neutralizing antibody fragments
that can later be transferred to plant expression systems, either
as antibody fragments or as full-length antibodies (Wieland
et al., 2006). An important limitation of this approach is the sig-
nificant heterogeneity of expression levels in the plant, appar-
ently because of differences in stability conferred by the
antibody variable regions, which might be exacerbated by the
use of synthetic or semisynthetic libraries. A possible solution to
this is the introduction of a quick selection step for in planta
stability using transient expression analysis, preferably per-
formed in the same plant organ used for the production of the
compound. Based on this rationale, we designed a set of shut-
tle vectors to facilitate the transfer of the coding sequences for
V regions from a phagemid library into plant expression vectors
and then took advantage of a fruit transient expression assay
(Orzaez et al., 2006) to test the expression levels of a subset of
the plant-produced antibodies against the model rotavirus strain
SA11.
DNA fragments that encoded single-chain antibody frag-
ments (scFv) that had been selected for their recognition of the
VP8* peptide of rotavirus VP4 protein were inserted into plant
expression cassettes carrying the constant regions of human IgA
(Figure S1a,b). To gain versatility in the cloning strategy, a Gate-
way-based set-up was established. Two Gateway pENTR vectors
(pENTR_IgH and pENTR_IgL) were generated containing the
constant regions of IgHa1 and Igk, respectively. Convenient
restriction sites were engineered at the 5¢ ends of each constant
region to allow for the direct cloning of the variable region of
the heavy chain (VH) and variable region of the light chain (VL)
derived from the Griffin.1 phage display library (Figure S1a).
The variable regions from three different anti-VP8* scFv (namely
2A1, 2E4 and 2B3) were introduced into the pENTR vectors and
transferred to the binary vector pKGW7 through site-specific
recombination reaction between attL and attR sites (LR recombi-
nation). As a result, plant expression constructs were generated
containing either the heavy chain (HC) or the light chain (LC) of
a fully reconstituted IgA antibody under the control of the
constitutive 35S promoter.
The in planta expression of each reconstituted antibody was
initially tested using an Agrobacterium-mediated transient
expression assay. Plant expression vectors carrying the genes
encoding the HC and the LC for each antibody to be analysed
were transferred to Agrobacterium and infiltrated into tomato
fruits. The high cotransformation efficiency provided by the fruit
agroinjection approach allowed for facile monitoring of the for-
mation of full-length IgA in fruit cells. As shown in Figure 1a,
only the variable regions derived from scFv 2A1 yielded coex-
pression of HC and LC proteins in planta as detected in Wes-
tern analysis under nonreducing conditions. When IgA_2E4 and
IgA_2B3 were transiently cotransformed, only LCs were
detected, whereas their respective HCs remained undetectable.
A 35SCaMV:GFP construct was included in all transformations
and used to normalize the transformation efficiency in the sam-
ples. Transient expression analysis using KDEL-tagged versions
of the IgA_2A1 HC and LC demonstrated that endoplasmic
reticulum (ER) retention resulted in higher antibody yields
(Figure S2). The transient expression data encouraged us to
continue with the stable plant transformation of the IgA_2A1
idiotype using HC and LC fused to a KDEL peptide as an ER-
retention signal. For this purpose, an in trans cotransformation
strategy was followed (referred as 35S_IgA): tomato explants
were simultaneously co-inoculated with two Agrobacterium cul-
tures carrying 35S:IgH2A1-kdel and 35S:IgL2A1-kdel expression
cassettes, respectively.
In addition to the above-mentioned in trans cotransformation
experiment, an in cis cotransformation approach was also car-
ried out (referred as NH_IgA). In this case, in order to prevent
the duplication of the 35S promoter, LC was placed under the
(a)
G
FP
2E
4
2B
3
2A
1
R/HC
R/LC
R/GFP
35
S_
Ig
A
35
S_
Ig
A
35
S_
Ig
A
W
T
W
T
W
T
Leaf Fruit
N
H
 1
A
-1
3-
2
N
H
 II
I6
-2
-6
35
S 
20
A
7
35
S 
17
A
-4
N
H
 1
A
-1
3-
2
N
H
 II
I6
-2
-6
35
S 
20
A
7
35
S 
17
A
-4
H
.S
.
NR/
HC
NR/
LC
R/
HC
R/
LC
R/HC R/LCCS
191 -
64 -
51 -
191 -
64 -
51 -
64 -
51 -
39 -
39 -
28 -
64 -
51 -
39 -
28 -
(b)
(c)
kDa
kDa
Figure 1 Western blot analysis of IgA expression in tomato. (a) Tran-
sient expression analysis of scFV-derived 2E4, 2B3 and 2A1 antibodies
using direct fruit agroinjection. Fruits were co-agroinjected with ER-
retained heavy and light antibody chains, together with GFP as internal
control. (b) Western blot analysis of leaves and fruits from best-perform-
ing T3 lines from in cis (NH) and in trans (35S) transgenic approaches.
Three fruits from each elite T3 plant were pooled in each representative
sample. All fruits were labelled at breaker stage and collected between
48 and 72 h later (c) Comparison between fruit extracts of 35S_20A7
and wild-type (WT) plants. Samples were resolved under either reducing
(R) or nonreducing (NR) conditions and decorated using anti-heavy-chain
antibody (HC), anti-light-chain antibody (LC), anti-GFP antibody (GFP) or
by Coomassie staining (CS). HS lane contains control human serum.
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control of the tomato NH promoter. The NH promoter drives
high levels of gene expression predominantly in fruits at
mature-green stage (Estornell et al., 2009). Therefore, a dual
construct was made (as depicted in Figure S1b) carrying
35S:IgH2A1-kdel and NH:IgL2A1-kdel expression cassettes
located within the same T-DNA.
Transgenic fruits accumulate high levels of mAb
Primary transformants from cis and trans cotransformation
approaches were selected by kanamycin resistance, and the
expression of HC and LC was confirmed by Western blots. IgA
expression levels in T1 generation were evaluated by ELISA, and
the best-performing lines were self-pollinated up to T3 for high
antibody titres and homozygosity. The description of two
selected T3 lines per construct (NH_1A-13-2 and NH_III6-2-6
from the NH_IgA approach and 35S_20A7 and 35S_17A4 from
the 35S_IgA approach) is presented here.
Western analysis of NH_IgA lines showed low IgA levels in
leaves when compared with fruits (Figure 1b). Interestingly,
when samples were analysed under reducing conditions, it was
found that not only LC but also HC was nearly absent in leaves,
suggesting that HC does not accumulate at significant levels in
the absence of its cognate LC. Notably, a significant portion of
the total antibody content in NH_IgA samples under nonreduc-
ing conditions was present in the form of a 45-kDa band, which
reacted with both anti-HC and anti-LC antibodies. Furthermore,
reducing conditions clearly showed a 25-kDa degradation band
that was recognized by anti-HC antibody, while the LC remained
intact. Together, these observations indicate that a significant
proportion of total IgA was present in the form of Fab’ frag-
ments, probably as a result of the cleavage of the full IgA per-
haps in the hinge region. IgA production levels were quantified
by ELISA in the fruits of the NH_1A-13-2 homozygous line,
reaching 15.6 ± 1.2 lg IgA equivalents ⁄ g fresh weight (FW)
[1.1 ± 0.1% total soluble protein (TSP)] (Table 1).
The in trans cotransformation strategy (35S_IgA) resulted in
20% (4 of 20) of the T1 kanamycin-resistant plants showing
both HC and LC expression in vegetative tissues. Following the
same minibreeding strategy as for the NH_IgA plants, lines
35S_20A7 and 35S_17A4 were selected for further character-
ization. In contrast to the NH_IgA lines, 35S_IgA plants showed
similar expression levels in fruits and vegetative tissues by
Western blot analysis, when gel loads were equalized per total
protein content in the sample (Figure 1b). As in the NH_IgA
approach, a significant part of the total antibody content in the
leaves and fruits of the 35S_IgA plants was present in the form
of Fab’ fragments, resulting from the association between par-
tially degraded HC (Figure 1b, R ⁄HC panel) and intact LC (R ⁄ LC
panel). In absolute terms, 35S_IgA approach resulted in higher
levels of recombinant protein production, reaching 41.2 ±
2.8 lg of IgA equivalents ⁄ g FW in fruits of elite T3 line
35S_20A7, equivalent to 3.6 ± 0.8% of TSP (Table 1). This
remarkable antibody accumulation is partially because of the
low total protein content in fruits. By comparison, IgA levels of
up to 90 lg IgA ⁄ g FW were achieved in the leaves of the same
elite plant, representing only 1% of TSP in those organs. Accu-
mulation of IgA in fruits is illustrated in Figure 1c, where the
full-size LC and the HC fragments are clearly observable as
25-kDa bands in Coomassie-stained gels, while the full-size HC
band remains masked by the comigrating 55-kDa bands in
crude fruit extracts.
Anti-VP8* activity is maintained in late ripening fruits
in the form of Fab’ fragments
The important physiological changes taking place during fruit rip-
ening are likely to affect the accumulation of recombinant anti-
bodies in the fruit. To learn about the effect of ripening on
antibody accumulation, activity and stability, 35S_20A7 and
NH_1A-13-2 tomatoes at different ripening stages [mature
green, breaker, red and red ripe (RR)] were analysed by antigen-
specific ELISA to assess the specific VP8* binding activity and by
Western blot to check for antibody integrity. In addition, red
ripened tomatoes that had been air-dried at room temperature
during 1 month were also analysed (dried tomato samples).
As shown in Figure 2a, the anti-VP8* activity, expressed rela-
tive to fruit FW, declines stepwise during ripening, with mature
green tomatoes showing maximum activity. This decline is
stronger in NH_1A-13-2 than in 35S_20A7 tomatoes. Remark-
ably, 35S_20A7 fresh red ripened tomatoes, and notably dried
tomatoes, still maintain 1 ⁄ 3 of the maximum activity. Ripening-
associated loss of anti-VP8* activity in 35S_20A7 tomatoes
apparently proceeds at slower pace than the overall decrease in
protein content associated with normal ripening, as anti-VP8*
specific activity (referred to total protein content) is maintained
even in the late ripening stages (Figure 2a). When these sam-
ples were analysed by Western blot (Figure 2b), it became clear
that a significant fraction of the full-length IgA is converted into
Fab’ fragments during late ripening. In contrast to full-length
IgA, Fab’ seems highly resistant to further degradation as it is
highlighted by the strong Fab’ band observed in 35S_20A7
tomatoes at the late ripe stage (Figure 2b, lanes RR and D).
Minimally processed tomato-based products show
strong anti-VP8* activity
The anti-VP8* binding activity of fruit-derived extracts was
determined using fruits from the elite line 35S_20A7. The
assays used antigen-ELISA plates coated with VP8* or with
bovine serum albumin (BSA) as a control. In order to test the
resistance of the antibody activity to downstream processing,
three tomato formulations compatible with long-term conserva-
tion and oral delivery were assayed, referred to as ‘juice’, ‘pow-
der’ and ‘dried juice’. ‘Juice’ consisted in a clarified extract from
frozen fruit samples ground in liquid nitrogen with phosphate-
buffered saline (PBS) (1 : 3) (w:v). The ‘powder’ format con-
sisted in freeze-dried ground tomato powder, later reconsti-
tuted in PBS using three volumes of the original FW. ‘Dried
Table 1 Total soluble protein (TSP) and IgA levels referred to TSP, fresh weight (FW) and dry weight (DW) of different tomato elite lines
Elite lines (t3) Genotype TPS (mg ⁄ g FW) IgA (% TSP) IgA (lg ⁄ g FW) IgA (lg ⁄ g DW)
35S_20A7 IgH ⁄ IgL 1.2 ± 0.2 3.6 ± 0.8 41.2 ± 2.8 686.9 ± 46.7
NH_1A-13-2 IgH ⁄ IgL 1.4 ± 0.1 1.1 ± 0.1 15.6± 1.2 259.6 ± 19.7
CR2-3-8 IgH ⁄ IgL ⁄ Ros1 ⁄ Del 1.7 ± 0.1 1.9 ± 0.3 33.5 ± 4.2 558.3 ± 70.3
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juice’ consisted in freeze-dried ‘juice’ sample, later reconstituted
in water using three volumes of the original FW. All samples
were clarified by centrifugation and incubated in serial dilutions
in an antigen-ELISA test. Control ‘juice’, ‘powder’ and ‘dried
juice’ samples from wild-type Moneymaker fruits also were pre-
pared as described earlier. For all three products, a strong anti-
VP8* binding activity was observed, which was not detected in
formulations prepared from wild-type samples or with control
assays that used BSA. Antibody binding titres showed consistent
behaviour, as all three samples reached endpoint titres at
1 ⁄ 512 dilutions (w ⁄ v) (Figure 3). The full conservation of anti-
body binding activity in ‘powder’ and ‘dried juice’ formats is
particularly promising for oral delivery, as dried formulations
also ensure an increase in antibody dosage. In the case of
35S_20A7 tomatoes, because dry weight represents 6% of the
total FW, the recombinant antibody levels in the ‘powder’ sam-
ples reach remarkable levels up to 0.68 mg of IgA equivalents
per gram of dry weight (Table 1).
Minimally processed fruit samples show strong
rotavirus neutralization activity
Once the VP8* binding activity of the IgA_2A produced in the
fruit was determined, the next steps consisted of (i) testing the
rotavirus neutralizing activity of the recombinant antibody
expressed in fruit and (ii) evaluating the possible effect of the
context conferred by the remaining components of the tomato
extract in the neutralization capacity. Affinity-purified recombi-
nant IgA was obtained from 35S_20A7 mature green fruits
using SSL7-agarose chromatography columns. The SSL7 protein
specifically binds the hydrophobic interface between the Ca2
and Ca3 domains of the Fc portion of the HC. The purification
steps were monitored by antigen-ELISA and Western blot, and
the presence of contaminant proteins in the final elution was
tested with silver-stained gels. Single-step affinity purification
with SSL7-agarose resulted in moderate 3.5· enrichment in
antibody activity with respect to the crude starting extracts
(Figure 4a). A significant part of the total activity was detected
in the flow-through fraction. This is probably because the Fab’
fragments do not bind SSL7 because of the lack of Fc domain,
as observed in the Western blot analysis in Figure 4b. Silver-
stained PAGE of eluted fractions in Figure 4b illustrates the level
of purification of the full-size recombinant IgA obtained after a
single-step affinity purification with the SSL7 agarose.
Neutralization activity against SA11 rotavirus was determined
by means of immunofluorescence assays on MA104 cell mono-
layers. The assays were performed by a previous incubation of
rotavirus with serial dilutions of the IgA samples, followed by
the infection of the formed monolayer with the resulting mix-
ture. In a first assay, serial dilutions of the SSL7-purified IgA
were compared with samples treated with PBS as mock treat-
ment controls. The neutralization capacity of the sample is rep-
resented in Figure 5a as the percentage of foci reduction with
respect to the number of foci produced by the control treat-
ment. IgA dilution series started with 30 lg ⁄mL, with minimum
significant titres (>60%) obtained with 3.75 lg ⁄mL of IgA and
a calculated IC50 value of 2.5 lg ⁄mL.
0
200
400
600
0
100
200
300
MG BK R RR DRYA
bs
49
2/
m
g 
pr
ot
ei
n
A
bs
49
2/
g 
FW
Ripening stages
35S_20A7
R/LC
R/HC
NR/HC
35S_20A7 NH_1A-13-2
MG   BK    R   RR  D   HSMG   BK    R   RR  D   HSkDa
64 
51 
39 
28 
28 
191 
64 
51 
39 
28 
kDa
64 
51 
39 
28 
28 
191 
64 
51 
39 
28 
(a)
(b)
0
100
200
300
0
50
100
150
MG BK R RR DRYA
bs
49
2/
m
g 
pr
ot
ei
n
A
bs
49
2/
g 
FW
Ripening stages
NH_1A-13-2
Figure 2 IgA accumulation profile during tomato fruit ripening. (a) Evolution of anti-VP8* activity in the fruit extracts of 35S_20A7 and NH_1A-13-2
elite plants referred to FW (light grey) and total protein content (dark grey columns). (b) Western blot analysis of the same fruit samples as in (a). Sam-
ples were resolved under either reducing (R) or nonreducing (NR) conditions and decorated using anti-heavy-chain (HC) or anti-light-chain antibodies
(LC). The selected fruit developmental stages were mature green fruits (MG), corresponding to fully expanded green fruits (4–5 weeks after anthesis);
breaker fruits (BK) turning yellow ⁄ red; red fruits (R), harvested between 5 and 12 days after breaker stage; red ripe fruit (RR), harvested between 14
and 21 days after breaker stage; and dry (D) tomatoes, harvested at the red ripe stage and stored at room temperature for 1 month. HS is a sample
of human serum. All samples were obtained by pooling three fruits from each developmental stage and analysed in triplicate with bars representing
standard error.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 10, 341–352
Paloma Jua´rez et al.344
Once the neutralization capacity of the recombinant IgA pro-
duced in tomato fruit was demonstrated, different assays were
carried out using different minimally processed tomato fruit
extracts, all of which were suitable candidates for therapeutic
delivery. For this purpose, the IgA content of ‘juice’ and ‘pow-
der’ samples from the 35S_20A7 tomatoes was estimated by
ELISA. Serial dilutions of the same samples were assayed for
rotavirus neutralization along with equivalent ‘juice’ and ‘pow-
der’ samples from wild-type tomatoes as reference controls.
Both ‘juice’ and ‘powder’ samples of IgA fruits showed similar
neutralization curves, with IC50 values of 1.8 and 2.0 lg ⁄mL,
respectively (Figure 5b). In these samples, neutralization titres
>60% were obtained with 3.7 lg ⁄mL of IgA equivalents. This
approximately corresponds to a 1 ⁄ 12 dilution of the original
IgA content in fresh fruits and 1 ⁄ 192 (w:w) of the IgA abun-
dance in the fruit powder. Although IC50 values of purified and
unpurified IgA samples are very similar, it is interesting to notice
that ‘powder’ and to a lesser extent ‘juice’ samples when
employed at low dilutions (equivalent to 7.5 and 15 lg IgA ⁄mL)
are more effective in foci reduction than equivalent concentra-
tions of purified IgA (Figure 5a). An image of the effect of
tomato IgA on the reduction of rotavirus infective foci is shown
in Figure 5c.
Rosea1 and Delila transgenes can be used to confer
identity preservation to IgA-expressing tomatoes
Recombinant biofactory strategies involving food crops may
benefit from the introduction of labelling traits. Recently, trans-
genic Del ⁄ Ros1 MicroTom tomato fruits with an intense purple
colour have been described (Butelli et al., 2008). Several
traditionally red tomato cultivars are known to display a bronze
coloration owing to the accumulation of anthocyanins in the
peel. In contrast, Del ⁄ Ros1 accumulates large amounts of
anthocyanins not only in the peel of the fruit, but also in the
pericarp and jelly tissues. This feature makes Del ⁄ Ros1 tomatoes
ideal for transgenic labelling and makes traceability easier for
both fruit biofactories and their derived ‘juice’ and ‘powder’
products.
Del ⁄ Ros1 genotype was initially introduced into the dwarf,
cherry tomato MicroTom cultivar. However, large globe-type
tomatoes are preferable in fruit biofactory strategies to maxi-
mize yields of fruit material. With this goal in mind, purple-
fruited MicroTom Del ⁄Ros1 plants (kindly provided by Prof.
Martin) were crossed with globe-type, wild-type Moneymaker
plants. The offspring showing combined globe-type and purple
phenotypes were single-seed selected up to the F7 generation.
A plant from the F7 generation was sexually crossed with a T1
35S_IgA-expressing line (35S_3), and the offspring of this cross
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were screened in an antigen-ELISA for IgA expression. Eight of
thirteen plants were found to be IgA positive and were grown
to maturity (referred as CR lines). All of them resulted in a pur-
ple-coloured fruit phenotype. Moreover, this colour trait was
maintained during fruit processing steps, as ‘juice’ and ‘powder’
samples showed a clearly distinguishable purple colour, in con-
trast with the light red colour of wild-type-derived products
(Figure 6a). Fruits from the F1-generation CR lines were then
tested for IgA expression, showing maximum antibody levels of
6.2 lg ⁄ g FW (0.8% TSP). CR lines were then self-pollinated to
F3 generation. As a result, an elite F3 plant with purple fruit,
called CR2-3-8, showed maximum IgA expression levels of
33.5 ± 4.2 lg IgA ⁄ g FW, equivalent to 1.9 ± 0.3% TSP, which
is a level comparable to that found in the red-fruited T3
35S_20A7 line (shown in Table 1). Endpoint ELISA titres of
tomato powder were also conducted, showing titration curves
consistent with the estimated IgA levels and confirming the
conservation of the biological activity of the IgA expressed in
the purple fruit (Figure 6b). Finally, the neutralization activity of
IgA powder from purple fruit was confirmed in virus neutraliza-
tion (VN) assays (Figure 6c). In these assays, disruption of the
cell monolayer was observed when samples derived from purple
powder were incubated at low dilutions (up to 1 : 12 w:v, not
shown). To dissect any possible effect of the anthocyanin back-
ground on the cell monolayer, VN titres of the CR2-3-8 ‘pow-
der’ samples were performed at dilutions above the cell
disruption threshold (1 : 24 w:v onwards) using an IgA-free sib-
ling purple-fruited line CR2-3-5 as a control. Purple IgA-express-
ing tomato fruit samples also strongly neutralized rotavirus,
with a calculated IC50 value of 1.98 lg ⁄mL of IgA (Figure 6c), a
value similar to that observed previously in the red tomato
‘powder’.
Discussion
Diarrhoeas caused by enteric pathogens kill an estimated
2.5 million infants worldwide per year (Kosek et al., 2003), and
500.000 of the fatalities are caused by rotavirus alone (Parashar
et al., 2003). Recently, two Jennerian vaccines against rotavirus
have been successfully launched. However, challenges remain
regarding the potential effectiveness of oral live vaccines in
developing countries in view of the prevalence of competing
intestinal flora in children, the occurrence of mixed infections,
the high levels of maternally transmitted antibodies and general
malnutrition. Recombinant production of rotavirus antigens in
plants has been proposed as an alternative to traditional pro-
duction platforms (Birch-Machin et al., 2004; Choi et al., 2005).
In addition, passive oral immunization emerges as a comple-
mentary strategy, as this approach has repeatedly been shown
effective against enteric infections (Corthesy, 2002). In this con-
text, the availability of an inexpensive source of neutralizing
antibodies for mucosal protection might serve as a valuable
complement to current vaccination strategies. This work shows
that recombinant antibodies against the model rotavirus strain
SA11 accumulate to considerable levels in tomato fruits and
that neutralizing antibody preparations can be obtained from
edible fruit tissues using extremely simple processing steps.
Therefore, these results suggest that the production of antibod-
ies in edible fruits can serve as an economically viable comple-
ment for combating enteric diseases, particularly in developing
countries.
Oral delivery of minimally processed products derived from
edible plant organs has been successfully assayed in both active
and passive immunization models. In active vaccination strate-
gies, the context provided by the plant tissue has been eventu-
ally shown to positively influence protection. This might be
related to the natural antigen encapsulation provided by plant
cells and the adjuvant effect provided by some of the compo-
nents of the plant extract. The alkaloid tomatine has been pro-
posed as an adjuvant, potentiating the response observed when
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Figure 5 In vitro rotavirus neutralization assays. Trypsin-activated rotavi-
rus of SA11 strain (10.000 ffu ⁄mL) was pre-incubated for 1 h with serial
dilutions of IgA-containing samples or equivalent control samples and
used to infect MA104 cell monolayers (2 · 104 cells ⁄well). Infective foci
were detected after 18 h by immunofluorescence and analysed in tripli-
cate with bars representing standard error. (a) Neutralization titres of
affinity-purified tomato-made IgA_2A1. (b) Neutralization titres of mini-
mally processed products. IgA content in ‘juice’ and reconstituted ‘pow-
der’ samples was estimated by sandwich ELISA and equalized with the
addition of phosphate-buffered saline (PBS). Equivalent wild-type ‘juice’
and ‘powder’ samples were equally diluted in PBS and used as controls
to estimate the percentage of neutralization of each sample. All samples
consisted of at least three pooled fruits from either elite 35S-20A7 or
wild-type Moneymaker plants. (c) Example of foci reduction conferred
by incubation with tomato-made IgA. Left: wild-type ‘juice’; right:
transgenic ‘juice’.
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tomato-made norovirus virus-like particles were used for oral
delivery (Zhang et al., 2006). In another example, oral boosts
with chloroplast-made plague fusion antigen F1-V without stan-
dard adjuvants but delivered as crude plant material performed
as well as adjuvated subcutanous boosts (Arlen et al., 2008).
More recently, a chloroplast-based strategy using lettuce as
production platform conferred dual protection against cholera
and malaria in mice (Davoodi-Semiromi et al., 2010). In the
veterinary field, oral passive protection using plant extracts has
been sucessfully reported in pigs for protection against trans-
misible gastroenteritis virus (Monger et al., 2006) and in poul-
try for protection against coccidiosis (Zimmermann et al.,
2009). In the latter case, pea-derived scFv against Eimera pro-
tozoa showed an enhanced prophylactic activity. It is likely
that protease inhibitors present in pea seeds might contribute
to the higher stability of the protein and therefore enhanced
protection. Herein, we show that preparations of IgA-express-
ing tomato fruit are at least as efficient as purified recombi-
nant IgA in neutralizing rotavirus infection, indicating that (i)
neutralizing activity is not affected by processing and (ii) the
Fab’ fragments predominant in fruit tissues are efficient for
VN. Moreover, the ‘juice’ and especially the ‘powder’ formula-
tions seemed even more effective than purified IgA in prevent-
ing rotavirus infection. This could be explained by a protective
role of the extract in the stability of the antibody or by the
contribution of additional components of the extract acting
cooperatively with the antibody in neutralizing the infection.
The effect of the edible plant extracts to enhance VN needs
further investigation, as it may boost the effectiveness of
passive protection strategies.
Tomato is a highly productive largely self-pollinated crop that
is well adapted to greenhouse cultivation under the confined
conditions required for molecular farming. Having low protein
content per fresh weigh, fruits have sometimes been discarded
as potential biofactories. However, as demonstrated here, once
water is removed from the fruit by drying, the antibody produc-
tion in fruit approaches highly competitive levels of gram per
kilogram of dry weight. Considering an average production of
6 kg of tomato (FW) per plant, current IgA yields in fruits would
lead to production levels reaching 0.5 g of antibody (IgA plus
Fab’s) per tomato plant, which can be administered as semi-
crude formulations where the remaining components are gener-
ally regarded as safe. Moreover, downstream processing may
benefit from ‘state of the art’ tomato food ⁄ beverage processing
technology. For instance, liquid spry-drying, a process increas-
ingly used in antibody formulation (Maa et al., 1998), is also
employed in the food industry for the production of tomato
powder (Santos de Sousa et al., 2008). Furthermore, the avail-
ability of single-step affinity purification systems as the SSL7-
agarose described here offers an economically relevant tool to
obtain partially purified formulations with increased concentra-
tion and ⁄ or safety profile.
Zhou et al. (2008) reported an almost complete disappear-
ance of HIV recombinant antigens upon ripening in transplas-
tomic tomato fruits and therefore proposed the use of
green-fruited tomato varieties for molecular farming. Ripening
seems to affect the protein biosynthesis capacity in plastids
more drastically than in the nucleus ⁄ cytoplasm. We found only
a moderate decrease in the activity levels of nuclear-encoded
antibody in ripened fruit. Moreover, the stability of Fab’
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Figure 6 Purple tomatoes anti-VP8*. (a) Tomato fruit, ‘powder’ and ‘juice’ samples from WT (right) and Del ⁄ Ros1 ⁄ IgH ⁄ IgL tomatoes (left); (b) End-
point anti-VP8* ELISA titering of purple and red tomato ‘powder’. Samples were obtained by pooling three fruits from each plant, namely a wild-type
plant (WT), the IgA-free control purple plant CR2-3-5 (Del ⁄ Ros1), the elite IgA-containing 35S-20A7 plant (IgA) and CR2-3-8 (IgA ⁄Del ⁄ Ros1), respec-
tively. Samples were titrated in triplicates against VP8* or bovine serum albumin (only CR2-3-8 line), with bars representing standard error. (c) Virus
neutralization assay of purple IgA tomatoes. The IgA content in a ‘powder’ sample consisting of three pooled fruits from the elite line CR2-3-8 was
estimated by sandwich ELISA. ‘Powder’ samples from CR2-3-8 and its Del ⁄ Ros1-positive, IgA-negative sibling line CR2-3-5 were reconstituted in phos-
phate-buffered saline in equivalent dilution series and pre-incubated with rotavirus SA11 prior to infect MA104 cell monolayers. Samples were analysed
in triplicate, and neutralization is represented as the mean percentage of the reduction in foci number with respect to the CR2-3-5 control line, with
bars representing the standard error.
ª 2011 The Authors
Plant Biotechnology Journal ª 2011 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd, Plant Biotechnology Journal, 10, 341–352
Purple tomatoes against rotavirus 347
fragments during ripening and postharvest seems key in the
maintenance of the neutralizing activity. The use of green-
fruited tomatoes is, nevertheless, an interesting proposal also
for nuclear-encoded transgenes, as it may contribute to further
increases in yields. Further pyramiding of ripening-related genes
could lead to new tomato varieties better adapted to molecular
farming. For example, by disrupting ripening-associated disad-
vantageous traits (e.g. protease activity or chromoplast transi-
tion), while preserving others (e.g. reduction in antinutrients or
responsiveness of engineered promoters), the deleterious effects
of ripening on pharmacological production may be obviated.
IgA_2A1 made in tomato fruit was engineered for in planta
production by inserting the variable regions of scFv_2A1 into
the constant regions of human IgA and by placing the resulting
antibody coding regions under the control of plant promoters.
A single-chain 2A1 antibody fragment was previously isolated in
a phage display screening against VP8* peptide, a rotavirus sur-
face antigen known to induce neutralizing antibody responses
(Higo-Moriguchi et al., 2004). It is generally accepted that
broad-spectrum passive immunization against intestinal patho-
gens including rotavirus will benefit from polyclonal mixes of
neutralizing antibodies. This could be achieved either by com-
bining different monoclonal transgenic lines or by engineering
single transgenic lines producing a combination of monoclonal
antibodies. In both cases, phage display constitutes an interest-
ing source of antigen-binding variable regions for in planta pro-
duction. However, we and others (Wieland et al., 2006;
Ballester et al., 2010; Verma et al., 2010) have repeatedly
observed strong differences in the stability of different phage
display–derived scFv or scFv-reconstituted full-size antibodies
when expressed in planta. Therefore, when using phage display
as a source for variable antibody regions, it is important to iden-
tify stable antibody idiotypes before undertaking stable transfor-
mation. For this, it is crucial to establish (i) flexible tools for scFv
grafting and (ii) fast in planta expression systems, preferably in
the same tissues in which the final production is intended. In
our laboratory, we previously developed a transient expression
system for tomato fruits known as fruit agroinjection, which
allows facile construct testing in fruit tissues such as placenta,
gel and inner pericarp (Orzaez et al., 2006). In addition, we
have adopted a grafting procedure based on restriction ⁄ ligation
and Gateway recombination that facilitates the cloning of new
variable regions into IgA constant regions. The need for an
in planta selection step is illustrated in this work. We took
advantage of the aforementioned tools to select among three
anti-VP8* full-length antibodies, two of which had to be dis-
carded prior to stable transformation as they showed very low
levels of HC accumulation.
In the final design of the recombinant antibody, a number of
additional decisions were made. The endogenous signal peptide
(SP) was substituted with the SP of a pectate lyase expressed in
fruit to ensure processing of the IgA protein in the fruit tissues.
IgA was chosen as full antibody isotype, as it will facilitate, if
required for increased efficiency, further conversion into secre-
tory IgA (Ma et al., 1995; Crottet and Corthesy, 2001). Two
transformation approaches were undertaken, involving in trans
and in cis cotransformation, the latter using an additional fruit-
operating NH promoter (Estornell et al., 2009). The NH_IgA
approach resulted, as expected, in very low expression in
vegetative tissues compared with fruits. Fruit-specific expression
may be appreciated as a biosafety measure and may avoid the
diversion of synthetic capacity of the crop towards unprofitable
protein production in vegetative tissues. However, in this case,
the in trans strategy employing the same 35S promoter for
both HC and LC yielded higher IgA levels in fruits. The 35S pro-
moter has been previously shown to operate at high levels in
fruits during development and ripening (Estornell et al., 2009)
and may have contributed to the high IgA expression levels in
spite of a general decline in transcriptional activity that takes
place during late ripening.
The high accumulation of ER-retained IgA_2A1 observed in
transient fruit expression assays prompted us to use ER reten-
tion in stable versions of IgA expression. This effect has been
reported repeatedly for plant-made antibodies (Orzaez et al.,
2009) and may be indicative of a lower level of protease activity
in the ER milieu. ER retention prevents complex glycosylation in
the Golgi apparatus, particularly the addition of fucose and
xylose plant-specific residues. It has been argued that the pres-
ence of immunogenic fucose and xylose in plant-made antibod-
ies could lead to allergic reaction, and ER retention could be
used as a preventive measure (Sriraman et al., 2004). However,
it is unlikely that these residues are allergenic through the
mucosal route given the continuous exposure of mucosa to
plant glycosylation patterns in food. Also, in the design of
hIgA_2A1, we incorporated the HCa1 coding region. IgA1 has
an extended shape compared with IgA2, as a result of an elon-
gated hinge region. It has been proposed that the IgA1 shape
facilitates the cross-linking of viral particles and therefore might
provide specialized functions in the protection against viral
pathogens (Bonner et al., 2009).
Edible plant organs provide clear advantages in particular
molecular farming approaches. However, the concerns about
contamination of the food chain with engineered contents are
often reasonably raised when pharmaceuticals are produced in
food crops. We propose here the use of natural coloured plant
compounds for labelling transgenic crops by means of meta-
bolic engineering. A relatively small amount of otherwise
health-promoting compounds such as anthocyanins, a natural
component in many edible berries, is sufficient to label IgA-pro-
ducing plants. These compounds confer an intense purple col-
our ensuring the traceability of transgenic fruits and their
derivatives. F1 plants coming from the initial crossing of purple
and IgA-expressing plants showed considerably lower IgA levels
than those measured in the elite T3 35S_IgA-expressing lines.
This raised the question of a possible dilution effect of the
recombinant protein production in the anthocyanin back-
ground. However, when purple IgA plants were bred up to F3,
a considerable increase in IgA content was observed, reaching
levels of 33.5 lg IgA ⁄ g FW, close to those reported for red IgA
plants (41.2 lg ⁄ g FW). This indicates that the anthocyanin
background has a minimal effect on the levels of IgA accumula-
tion in fruits. Moreover, IgA from the transgenically labelled
purple tomatoes also showed anti-VP8* binding and rotavirus
neutralizing activities similar to those described for red toma-
toes, again indicating that IgA activity is not affected by the
presence of anthocyanins. Disruption of cell monolayers was
observed in VN assays when samples derived from purple ‘pow-
der’ were incubated at low dilutions. It has previously been
reported that some phenolic compounds may react with
constituents of certain cell culture media (Long et al., 2010).
These reactions can result in the oxidation of phenol to produce
a range of toxic products such as H2O2. These effects can be
regarded as artifactual as they result from the interaction with
the culture media and are not likely to take place in vivo.
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Moreover, when VN assays were performed at dilutions above
the cell disruption threshold, the neutralizing effect of recombi-
nant IgA was evident.
A further degree of safety can be achieved by genetically
linking the antibody and the Del ⁄Ros1 modules (e.g. including
both modules in the same T-DNA). The same synthetic biology
rational can be used to include additional safety modules as
male sterility as well as any other with relevance to antibody
production as glycoengineering, decreased protease activity,
etc. leading to the design of highly optimized platforms for
molecular farming (Sarrion-Perdigones et al., 2011).
This is, to our knowledge, the first report showing viral
neutralization activity of a plant-produced antibody in minimally
processed edible fruit extracts. The results support the need for a
detailed investigation into the biosafety and in vivo effectiveness
of fruit-based passive immunization. Moreover, we created the
first example of a biofortified plant crop additionally displaying
prophylactic activity. The model plant designed here is an exam-
ple of how gene stacking, either by sexual crossing or by other
means, can lead to new agricultural products with added value
and new applications. The introduction of four transgenes
(HC, LC, Ros1 and Del) in a single tomato plant resulted in a com-
pletely new product: a transgenically labelled, orally safe, inex-
pensive fruit juice with a health-promoting (antioxidant) activity
(Butelli et al., 2008) and anti-rotavirus prophylactic potential.
Experimental procedures
DNA constructs and vectors
The DNA sequences corresponding to the constant regions of
human alpha heavy (HCa) and lambda light (LCk) antibody
chains were obtained from the human library clones EHS1001-
9024643 and EHS1001-9024145, respectively (Open Biosys-
tems, Huntsville, AL). LCk was PCR-amplified in a nested reac-
tion using D06mar01 and D06mar07 oligos as overlapping
forward primers and D06mar08 as reverse primer. D06mar01
and D06mar07 overlapping primers were used to fuse to the
5¢end of LCk a number of elements, namely an attB1 recombi-
nation site, a Kozak sequence, the SP from the tomato pectate
lyase and a small polylinker containing ApaLI and NotI restric-
tion sites. In another construct, the D06mar08 primer incorpo-
rated a KDEL peptide, a stop codon and an attB2
recombination site in the 3¢ end of the LCk coding region
(Table S1). The resulting LCk expression cassette still lacking the
sequence corresponding to the VL was BP-cloned in pDNOR221
vector, generating an ENTRY vector named as pENTR_LCk. In a
similar fashion, a pENTR_HCa vector was created for the conve-
nient cloning of variable regions of the HC into an IgCa frame.
In this case, cloning of HCa was preceded by a step of directed
mutagenesis designed to silently remove NcoI and XhoI sites
from HCa coding sequence. For this purpose, HCa was pre-
amplified in three contiguous fragments using oligonucleotide
pairs D03Mar00 ⁄D03Mar19, D06Mar03 ⁄D03Mar04 and
D03mar20 ⁄D03Mar06, respectively, and subsequently joined by
overlapping PCR. The resulting mutagenized HCa was reampli-
fied in a nested reaction with D06mar01 and D06mar02 as for-
ward primers, which incorporated attB1, the pectate lyase SP
and NcoI ⁄XhoI cloning sites. At the 3¢ end, the D06Mar06 pri-
mer incorporated a stop codon, the KDEL peptide and attB2.
The resulting HCa expression cassette was BP-cloned into
pDONR221 vector yielding pENTR_HCa vector.
The sequences of the variable antibody regions reacting
against VP8* were cloned from a previously described anti-VP8
scFv collection selected from the phage display human antibody
library Griffin.1 (Monedero et al., 2004). The Griffin.1 library is
a large naı¨ve human scFv phagemid library (total diversity of
1.2 · 109) constructed from synthetic V-gene segments made
by recloning the heavy-chain and light-chain variable regions
from the lox library vectors (Griffiths et al., 1994) into the
phagemid vector pHEN2. VL fragments (2A1, 2B3 and 2E4)
were ApaLI ⁄NotI-digested and cloned into pENTRY_LCk ApaLI ⁄ -
NotI sites, generating pENTR_IgL vectors. In parallel, VH frag-
ments (2A1, 2B3 and 2E4) were NcoI ⁄XhoI excised from
Griffin.1 vector and cloned in the equivalent sites of
pENTR_HCa, generating pENTR_IgHa vectors. To harbour the
expression cassettes of the individual antibody chains, pBIN-
JITGW and pKGW7.0 were used as destination vectors.
pKGW7.0 containing 35S promoter and terminator was kindly
provided by Karimi et al. (2002). pBINJGW was engineered by
introducing a Gateway cassette (Invitrogen, Carlsbad, CA) in
the SmaI site of pBINJIT plasmid, following manufacturer’s pro-
cedures. Binary expression vectors for heavy and light antibody
chains were obtained by performing LR reactions between
ENTRY vectors (e.g. pENTR_IgL_2A1 and pENTR_IgHa_2A1) and
binary destination vectors, generating plant antibody expression
clones (e.g. pEXP_ 35SIgL_2A1 and pEXP_ 35SIgHa_2A1).
Heavy and LCs expression cassettes were also combined in a
single binary vector under the constitutive 35S and the fruit-
operating NH promoters, respectively. For this purpose, the
IgL_2A1 coding region was PCR-amplified using primers
L07Nov07 and L07Nov08 containing attB4R and attB3R exten-
sions and BP-recombined into pDONR221P4r-P3r (Invitrogen),
generating pENTR4R3R_IgL2A1. A triple gateway recombination
reaction was then performed between vectors pENTR1-4_NH,
pENTR3-2_Tnos, both belonging to the previously described
pENFRUIT collection of combinatorial vectors (Estornell et al.,
2009), and pENTR4r3r_IgL2A1, using pKGW.0 as a destination
vector. In this way, an expression cassette was generated com-
prising the NH promoter fused to IgL-2A1 and the Tnos termi-
nator. The whole 4.9-Kb expression cassette was PCR-amplified
using primers L07Jun05 and L08Jan01, containing AscI and SalI
recognition sites, respectively. The resulting PCR fragment was
digested with AscI ⁄ SalI and cloned into pEXP_35SIgHa_2A1,
generating the binary plasmid pEXP_35SIgH_NHIgL, which com-
bines heavy and light antibody chains under the control of two
different promoters both operating in the tomato fruit.
Tomato transformation, plant material and sample
preparation
Plasmids were transferred to Agrobacterium tumefaciens
LBA4404 strain by electroporation and used for tomato stable
transformation (var. Moneymaker), as described previously (Ellul
et al., 2003). For transient expression, plant expression plasmids
were transferred to Agrobacterium tumefaciens strain C58 and
assayed transiently in MicroTom fruits, as described previously
(Orzaez et al., 2006). For sample preparation, plant tissues
(leaves and tomato fruit) were ground with a mortar and pestle
to a fine powder under liquid nitrogen and stored at )80  until
used. For ‘juice’ samples, proteins were extracted with three
volumes (w ⁄ v) of PBS pH 7.4. After mixing, the suspension was
centrifuged twice at 4 C at maximum speed and the superna-
tant was immediately used for further analysis. For ‘dried juice’
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samples, total protein was extracted in the same manner, fol-
lowed by a 24-h freeze-drying step. The sample was reconsti-
tuted in three volumes of water (w ⁄ v) for analysis. The
‘powder’ samples were obtained from fine tissue powder after
a 24-h freeze-drying treatment; total protein was extracted with
three volumes of PBS pH 7.4 (w ⁄ v), centrifuged twice at 4 C
at maximum speed, and the supernatant was used for the
analysis.
VP8* rotavirus surface protein production
Recombinant VP8* was obtained from pQEVP8*-transformed
Escherichia coli M11. Plasmid pQEVP8* was kindly provided by
Dr. Monedero from Instituto de Agroquı´mica y Tecnologı´a de
Alimentos (IATA, Valencia, Spain). VP8* expression was
performed using the QIAexpressionist protocol (http://www.qia-
gen.com). Frozen cell pellets were thawed in 20 mM Tris–HCl
pH 8.0. Cells were lysed by sonication on ice (6 · 25 s) and
washed with buffer A (20 mM Tris–HCl, 0.5 M NaCl, 2 M urea
and 2% Triton X-100) to isolate inclusion bodies. After 15 min
25.000 g spin, cells were sonicated (6 · 25 s) one more time
and washed again with the same buffer. A last wash with urea-
free buffer A was made.
Inclusion bodies were solubilized with 20 mM Tris–HCl, 0.5 M
NaCl, 6 M guanidine HCl, 5 mM imidazole and 1 mM 2-b-mer-
captoethanol at pH 8.0. The sample was stirred at room tem-
perature for 1 h and then centrifuged for 15 min at high
speed. The remaining particles were removed by passing the
sample through a 0.22-lm filter. Purification was performed
using HisTrap HP affinity columns (GE Healthcare, Buckingham-
shire, UK) following manufacturer’s procedures. Protein refold-
ing in column was performed with 30 mL of a lineal 6–0 M urea
gradient at a flow rate of 1 mL ⁄min, starting with buffer B
(20 mM Tris–HCl, 0.5 M NaCl, 6 M urea and 1 mM 2-mercapto-
ethanol) and finishing with urea-free buffer B. The refolded pro-
tein was eluted using a 10-mL lineal gradient starting with
buffer C (20 mM Tris–HCl, 0.5 M NaCl, 20 mM imidazole and
1 mM 2-mercaptoethanol) pH 8.0 and ending with the same
buffer C supplemented with 500 mM imidazole.
ELISAs for the detection of VP8* binding activity and
recombinant immunoglobulin A determination
Plates (Corning, New York, NY) were coated overnight with
10 lg ⁄mL of recombinant VP8* for the detection of VP8* bind-
ing activity or 2 lg ⁄mL of anti-human IgA a specific (Sigma
Aldrich, St. Louis, MO) for IgA determination, in coating buffer
(50 mM carbonate buffer pH 9.8) at 4 C. Plates were then
washed four times in PBS and blocked with a 2% (w ⁄ v) solu-
tion of ECL AdvanceTM Blocking agent (GE Healthcare) in PBS-T
[0.1% (v ⁄ v) Tween 20 in PBS]. Samples were diluted in PBS as
required for each assay and incubated for 1 h at room tempera-
ture. After incubation, plates were washed four times in PBS
and the anti-human IgA a-specific horse radish peroxidase (HRP)
1 : 5000 (Sigma Aldrich) in 5% blocking buffer (GE Healthcare)
in PBS-T was added and incubated for 1 h at room tempera-
ture. After four PBS washes, the substrate (o-phenilenediamine
from Sigma Aldrich) was added and the reactions were stopped
with 3 M HCl. Absorbance was determined at 492 nm. As a
control for specificity, plates were coated with 10 lg ⁄mL of
BSA. A sample was considered positive when its absorbance
was at least three times higher than the absorbance value of
the same sample in the control. Specific VP8* binding activity
was estimated using serial sample dilutions, dividing the absor-
bance at 492 nm of those dilutions falling within the lineal
range by the total protein content of each sample (mg). A stan-
dard curve from 0.8 to 0.1 lg ⁄mL of commercial IgA from
human colostrum (Sigma Aldrich) was obtained to calculate the
concentration of IgA in the different samples. IgA concentration
in each sample was obtained by interpolation with the IgA stan-
dard curve. For IgA quantification in elite lines, three samples
from each elite line were analysed and the mean ± SD for each
line was calculated.
SDS-PAGE and Western blot analysis
Proteins were separated by SDS ⁄ PAGE in 10% and 3%–8%
denaturing gels (Invitrogen). Gel staining was carried out either
with Coomassie blue or with silver staining following standard
procedures. For Western blot analysis, blots were incubated
with 1 : 20.000 anti-human IgA a-specific HRP (Sigma Aldrich)
for the detection of the HC and 1 : 10.000 anti-human k LC
(Sigma Aldrich) followed by 1 : 10.000 lg ⁄mL HRP-conjugated
anti-rabbit IgG (GE Healthcare) for the detection of the LC.
Blots were developed with ECL plus Western blotting Detection
System (GE Healthcare).
Protein SSL7 affinity purification
Protein extracts prepared as explained previously were further
clarified using a 0.22-lm Stericup (Millipore, Billerica, MA) on ice.
The clarified extract was directly used for purification with staphy-
lococcal superantigen-like protein 7 (SSL7) agarose columns from
InvivoGen (San Diego, CA) following manufacturer¢s protocol
with minor modifications. Wash buffer was substituted by PBS
(0.1 M phosphate and 0.1 M NaCl pH 7.4). Dialysis was not
needed as the samples were already in PBS and elution neutral-
ization was carried out mixing with PBS 1 : 1 (v ⁄ v).
Neutralization assays
Tomato IgA neutralization of rotavirus SA11 strain was assessed
by immunofluorescent focus reduction assays on MA104
(Health Protection Agency Culture Collection) cell monolayers in
96-well cell culture microplates (Corning) infected with rotavirus
(Asensi et al., 2006). The plates were coated with 2 · 104 cells
per well in minimum essential medium (MEM from Gibco-
Invitrogen, Carlsbad, CA) supplemented with 100 U ⁄mL penicil-
lin, 100 lg ⁄mL streptomycin, 2 mM glutamine, 0.7% CO3H and
10% foetal bovine serum (FBS) and incubated for 24 h at 37 C
in a CO2 stove until the monolayers were confluent. Rotavirus
suspensions [at two different concentrations, 2 · 103 and
1 · 104 fluorescing cell-forming units per mL (f.f.u. ⁄mL)] in
MEM without FBS were activated with 10 lg ⁄mL of trypsin type
IX (Sigma Aldrich) prior to the incubation with serial dilutions
(1 : 2 to 1 : 256) of IgA samples in MEM (FBS-free), and the
resulting mixes were used to infect the monolayers (1-h incuba-
tion at 37 C). After incubation, the monolayers were washed
with MEM and incubated for 18 h in MEM containing 1 lg ⁄mL
trypsin at 37 C in a CO2 stove. Four different IgA samples
were used in the different assays: ssl-7 purified recombinant
IgA in PBS, 35S_20A7 clarified fruit extract (‘juice’), freeze-dried
tissue samples from 35S_20A7 and CR2-3-8 fruits reconstituted
in PBS (‘powder’). PBS, ‘juice’ and reconstituted ‘powder’ from
fruits of wild-type Moneymaker or IgA-free purple-fruited CR2-
3-5 plants were used as mock solutions for comparisons. All
fruit samples were collected and processed between 2 and
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4 days after reaching the breaker stage. After incubation,
monolayers were fixed with 100 lL ⁄well of 1 : 1 (v:v) metha-
nol ⁄ acetone for 15 min and then washed with PBS. An anti-
rotavirus VP6 monoclonal antibody in PBS 1% BSA (1 : 80) was
applied as the primary antibody for 1 h at 37 C, followed by
three washes with PBS. The secondary antibody was an anti-
mouse IgG FITC-labelled (Sigma, Sigma Aldrich, St. Louis, MO)
(1 : 400). The monolayers were washed three more times with
PBS and stained with Evans blue for 5 min, washed again with
PBS and 20 lL of mounting fluid (Millipore) was applied to each
well. Images were obtained by excitation with 480-nm light and
acquired at 6.3· magnification factor using a Leica MZ16F
binocular equipped with a Leica DFC300FX digital camera and
Leica application suite software. The 50% inhibiting concentra-
tions (IC50) were calculated by the method of Reed and
Muench (Reed and Muench, 1938), using the concentrations
present during the antibody-virus pre-incubation step.
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